[
  {
    "ts": "2025-09-30T21:54:22+00:00",
    "headline": "US drugmakers rise after Trump announces Pfizer price cuts",
    "summary": "By Sneha S K (Reuters) -Shares of U.S. drugmakers rose after President Donald Trump said on Tuesday that Pfizer will cut the price of all prescription drugs in the Medicaid program for low-income",
    "url": "https://finance.yahoo.com/news/us-drugmakers-rise-trump-announces-215422715.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "21bfc0f8-7e0d-327a-a36e-a232f412f15a",
      "content": {
        "id": "21bfc0f8-7e0d-327a-a36e-a232f412f15a",
        "contentType": "STORY",
        "title": "US drugmakers rise after Trump announces Pfizer price cuts",
        "description": "",
        "summary": "By Sneha S K (Reuters) -Shares of U.S. drugmakers rose after President Donald Trump said on Tuesday that Pfizer will cut the price of all prescription drugs in the Medicaid program for low-income",
        "pubDate": "2025-09-30T21:54:22Z",
        "displayTime": "2025-09-30T21:54:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/f84a837a34402be20e28ea4e4f082212",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., September 30, 2025. REUTERS/Mike Blake",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ukb3.vs4A3lpMell.H1fDg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f84a837a34402be20e28ea4e4f082212.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/polq1OvvpZg0psSBg5E.SA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f84a837a34402be20e28ea4e4f082212.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/us-drugmakers-rise-trump-announces-215422715.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/us-drugmakers-rise-trump-announces-215422715.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T21:45:04+00:00",
    "headline": "Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know",
    "summary": "Bristol Myers Squibb (BMY) reached $45.1 at the closing of the latest trading day, reflecting a +2.15% change compared to its last close.",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-beats-214504454.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ffd59180-7463-321e-95b8-2db0d8024b34",
      "content": {
        "id": "ffd59180-7463-321e-95b8-2db0d8024b34",
        "contentType": "STORY",
        "title": "Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know",
        "description": "",
        "summary": "Bristol Myers Squibb (BMY) reached $45.1 at the closing of the latest trading day, reflecting a +2.15% change compared to its last close.",
        "pubDate": "2025-09-30T21:45:04Z",
        "displayTime": "2025-09-30T21:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0sIIP41M0Yl73BbPadjNMg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WsNU52Eg.hsicG83rNZXgw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-beats-214504454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-bmy-beats-214504454.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T20:47:00+00:00",
    "headline": "Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.",
    "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
    "url": "https://www.barrons.com/articles/pfizer-stock-price-trump-drug-price-plan-pharma-d2d4fb98?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "6adbb16c-c0b2-3173-bebd-3200eca0816f",
      "content": {
        "id": "6adbb16c-c0b2-3173-bebd-3200eca0816f",
        "contentType": "STORY",
        "title": "Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.",
        "description": "",
        "summary": "The president announced a federal government website that allows Pfizer to sell medicines at low prices to cash-paying consumers.",
        "pubDate": "2025-09-30T20:47:00Z",
        "displayTime": "2025-09-30T20:47:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6adbb16c-c0b2-3173-bebd-3200eca0816f/pfizer-stock-soars-on-trump%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/c78f72d53c2bc1961f54706964082161",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LwxUAPTOhNQPl1Dle3pLAA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/c78f72d53c2bc1961f54706964082161.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bpni_2bvAS1THSI946ZWaw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/c78f72d53c2bc1961f54706964082161.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/pfizer-stock-price-trump-drug-price-plan-pharma-d2d4fb98?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T18:49:34+00:00",
    "headline": "Bernstein Maintains a Hold on Bristol-Myers Squibb Company (BMY)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best large cap value stocks to buy now. In a report released on September 25, Courtney Breen from Bernstein maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY) without assigning a price target. Bristol-Myers Squibb Company (NYSE:BMY) reported $12.3 billion in revenues in fiscal Q2 2025, with […]",
    "url": "https://finance.yahoo.com/news/bernstein-maintains-hold-bristol-myers-184934597.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "e1cc8ff8-dd25-3d4c-94a9-0fa6347830f0",
      "content": {
        "id": "e1cc8ff8-dd25-3d4c-94a9-0fa6347830f0",
        "contentType": "STORY",
        "title": "Bernstein Maintains a Hold on Bristol-Myers Squibb Company (BMY)",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best large cap value stocks to buy now. In a report released on September 25, Courtney Breen from Bernstein maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY) without assigning a price target. Bristol-Myers Squibb Company (NYSE:BMY) reported $12.3 billion in revenues in fiscal Q2 2025, with […]",
        "pubDate": "2025-09-30T18:49:34Z",
        "displayTime": "2025-09-30T18:49:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-maintains-hold-bristol-myers-184934597.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bernstein-maintains-hold-bristol-myers-184934597.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T17:05:44+00:00",
    "headline": "Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best conservative stocks to buy now. On September 23, at the Bernstein Insights: Healthcare Leaders and Disruptors, the company emphasized its leadership in cell therapy. The remarks come on the company treating 13,000 patients with cell therapy while leveraging extensive clinical data. “As we sit four years […]",
    "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-080044734.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "138d4465-6b0c-3927-bb0b-0b577fb1175a",
      "content": {
        "id": "138d4465-6b0c-3927-bb0b-0b577fb1175a",
        "contentType": "STORY",
        "title": "Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best conservative stocks to buy now. On September 23, at the Bernstein Insights: Healthcare Leaders and Disruptors, the company emphasized its leadership in cell therapy. The remarks come on the company treating 13,000 patients with cell therapy while leveraging extensive clinical data. “As we sit four years […]",
        "pubDate": "2025-09-30T17:05:44Z",
        "displayTime": "2025-09-30T17:05:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/935e3f45062c9de47f2720fd0f677948",
          "originalWidth": 1843,
          "originalHeight": 1215,
          "caption": "Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r_Pe2hbRN1rjiMwLyyiJLw--~B/aD0xMjE1O3c9MTg0MzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/935e3f45062c9de47f2720fd0f677948.cf.webp",
              "width": 1843,
              "height": 1215,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2Z0lPCkVoDqMwqtKmKknA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/935e3f45062c9de47f2720fd0f677948.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-080044734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-080044734.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T14:18:00+00:00",
    "headline": "Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?",
    "summary": "KRYS gains momentum with Vyjuvek's expanded FDA label and global approvals, while advancing a pipeline led by oncology candidate KB707.",
    "url": "https://finance.yahoo.com/news/krystal-biotechs-heavy-reliance-vyjuvek-141800688.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e344fbc7-4f32-3c18-ae17-db72b5aaed57",
      "content": {
        "id": "e344fbc7-4f32-3c18-ae17-db72b5aaed57",
        "contentType": "STORY",
        "title": "Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor?",
        "description": "",
        "summary": "KRYS gains momentum with Vyjuvek's expanded FDA label and global approvals, while advancing a pipeline led by oncology candidate KB707.",
        "pubDate": "2025-09-30T14:18:00Z",
        "displayTime": "2025-09-30T14:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H9Y3er.afSc3GhCdnEPJDg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A8kFZZ9VHNy5RXuATQIZdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f2a2e04a053cda7a8c096e532e43d28.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/krystal-biotechs-heavy-reliance-vyjuvek-141800688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/krystal-biotechs-heavy-reliance-vyjuvek-141800688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "KRYS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-30T10:30:00+00:00",
    "headline": "Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus",
    "summary": "BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”",
    "url": "https://www.thedailyupside.com/industries/healthcare/genmab-strikes-8-billion-deal-for-rising-oncology-treatment-maker-merus/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "e579b81d-fac2-3790-a105-b1cd8fff32d9",
      "content": {
        "id": "e579b81d-fac2-3790-a105-b1cd8fff32d9",
        "contentType": "STORY",
        "title": "Genmab Strikes $8 Billion Deal for Cancer Treatment Maker Merus",
        "description": "",
        "summary": "BMO analysts said in a note Monday they were “encouraged” that Genmab’s acquisition “could start to spur broader M&A in the sector.”",
        "pubDate": "2025-09-30T10:30:00Z",
        "displayTime": "2025-09-30T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/60269bdae37122b894b271cc0f6a7888",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Photo of Genmab laboratory work.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DiSrHgSSnW1fK0xV_Q_47g--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/60269bdae37122b894b271cc0f6a7888.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J.ffSGwjQ0XefcqxTLSWiQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/60269bdae37122b894b271cc0f6a7888.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/genmab-strikes-8-billion-deal-for-rising-oncology-treatment-maker-merus/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/genmab-strikes-8-billion-deal-103000195.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "CELG-RT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GMAB.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]